Key Insights

Highlights

Treatment Research

4 treatments under study, led by Carboplatin

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05472220Phase 1Withdrawn

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

Showing all 1 trials

Research Network

Common Treatments

  • Carboplatin1
  • Alpelisib1
  • Hyperpolarized Carbon13 13c Pyruvate1
  • Continuous Glucose Monitor Cgm1

Active Sponsors

  • Pamela Munster1
  • Novartis1

Top Investigators

Related Conditions

  • Pik3ca Mutation1
  • Pik3ca Mutationrelated Tumors1
  • Locally Advanced Malignant Solid Neoplasm1
  • Solid Tumors Adult1
  • Human Papillomavirusrelated Carcinoma1

Activity Timeline